KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Pacific Biosciences Of California (PACB) over the last 9 years, with Q3 2025 value amounting to $18.1 million.

  • Pacific Biosciences Of California's Treasury Shares rose 1512.51% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 1512.51%. This contributed to the annual value of $14.2 million for FY2024, which is 2567.21% up from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Treasury Shares is $18.1 million, which was up 1512.51% from $18.9 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Treasury Shares peaked at $21.4 million during Q1 2025, and registered a low of $8392.0 during Q2 2022.
  • Its 5-year average for Treasury Shares is $12.0 million, with a median of $12.0 million in 2023.
  • Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 9987.7% in 2022, then skyrocketed by 15055538.61% in 2023.
  • Pacific Biosciences Of California's Treasury Shares (Quarter) stood at $7.4 million in 2021, then grew by 15.46% to $8.5 million in 2022, then skyrocketed by 32.49% to $11.3 million in 2023, then increased by 25.67% to $14.2 million in 2024, then grew by 27.53% to $18.1 million in 2025.
  • Its Treasury Shares stands at $18.1 million for Q3 2025, versus $18.9 million for Q2 2025 and $21.4 million for Q1 2025.